What is the AZD-6244?

AZD-6244 is , while it's Molecular Formula is C17H17BrClFN4O7S. Used in Oncology: AZD-6244 is used as an anticancer agent for the treatment of various cancer types, including melanoma, non-small cell lung cancer, and thyroid cancer. It targets the MEK1/2 pathway, inhibiting the activation of downstream kinases and the proliferation of cancer cells, thereby offering a potential therapeutic option for these malignancies. Used in Combination Therapy: AZD-6244 is used in combination with other therapeutic agents to enhance the efficacy of cancer treatment. Clinical trials have shown that the combination of AZD-6244 with other drugs can improve treatment outcomes and potentially overcome resistance to conventional chemotherapy. Used in Clinical Research: AZD-6244 is used as a subject of ongoing research to explore its potential in treating a range of cancer types. Researchers are investigating its efficacy, safety, and optimal dosing regimens to maximize its therapeutic benefits while minimizing side effects. Used in Drug Development: AZD-6244 serves as a valuable compound in the development of new cancer therapies. Its selective inhibition of the MEK1/2 pathway provides a foundation for the design of novel drugs targeting this pathway, potentially leading to the discovery of more effective and safer treatments for various cancers.

What is the CAS number for AZD-6244?

The CAS number of AZD-6244 is 943332-08-9.

What is AZD-6244 (943332-08-9) used for?

AZD-6244, also known as selumetinib, is a selective MEK1/2 inhibitor that has demonstrated potential in the treatment of cancer. It works by inhibiting the MEK1/2 pathway, effectively blocking the activation of downstream kinases and the proliferation of cancer cells. This targeted approach has positioned AZD-6244 as a promising therapeutic agent for various types of cancer.

What is the AZD-6244?

AZD-6244 is , while it's Molecular Formula is C17H17BrClFN4O7S. Used in Oncology: AZD-6244 is used as an anticancer agent for the treatment of various cancer types, including melanoma, non-small cell lung cancer, and thyroid cancer. It targets the MEK1/2 pathway, inhibiting the activation of downstream kinases and the proliferation of cancer cells, thereby offering a potential therapeutic option for these malignancies. Used in Combination Therapy: AZD-6244 is used in combination with other therapeutic agents to enhance the efficacy of cancer treatment. Clinical trials have shown that the combination of AZD-6244 with other drugs can improve treatment outcomes and potentially overcome resistance to conventional chemotherapy. Used in Clinical Research: AZD-6244 is used as a subject of ongoing research to explore its potential in treating a range of cancer types. Researchers are investigating its efficacy, safety, and optimal dosing regimens to maximize its therapeutic benefits while minimizing side effects. Used in Drug Development: AZD-6244 serves as a valuable compound in the development of new cancer therapies. Its selective inhibition of the MEK1/2 pathway provides a foundation for the design of novel drugs targeting this pathway, potentially leading to the discovery of more effective and safer treatments for various cancers.

What is the CAS number for AZD-6244?

The CAS number of AZD-6244 is 943332-08-9.

What is AZD-6244 (943332-08-9) used for?

AZD-6244, also known as selumetinib, is a selective MEK1/2 inhibitor that has demonstrated potential in the treatment of cancer. It works by inhibiting the MEK1/2 pathway, effectively blocking the activation of downstream kinases and the proliferation of cancer cells. This targeted approach has positioned AZD-6244 as a promising therapeutic agent for various types of cancer.

Factory Sells Best Quality Selumetinib sulfate 943332-08-9 with steady supply

 

Your Location：Home > Products > API&Intermediates > Selumetinib sulfate

Selumetinib sulfate

Product Name
CasNo
MF
MW
Content
Appearance
Packing
Apply

Selumetinib sulfate
943332-08-9
C17H17BrClFN4O7S
555.76

Inquiry 